Fragment-Based Design, Synthesis, and Biological Evaluation of 1-Substituted-indole-2-carboxylic Acids as Selective Mcl-1 Inhibitors

被引:16
作者
Wang, Ziqian [1 ]
Xu, Wenjie [1 ]
Song, Ting [2 ]
Guo, Zongwei [2 ]
Liu, Lu [1 ]
Fan, Yudan [2 ]
Wang, Anhui [1 ]
Zhang, Zhichao [1 ]
机构
[1] Dalian Univ Technol, Sch Chem, State Key Lab Fine Chem, Dalian 116012, Peoples R China
[2] Dalian Univ Technol, Sch Life Sci & Technol, Dalian, Peoples R China
基金
中国国家自然科学基金;
关键词
Fragment-based drug design; Ligand efficiency; Mcl-1; inhibitor; p1; pocket; Selective; BCL-2; FAMILY; DRUG DESIGN; ABT-737; DISCOVERY; PROTEINS; POTENT; ANTAGONISTS; RESISTANCE; APOPTOSIS; BIG;
D O I
10.1002/ardp.201600251
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Based on a known selective Mcl-1 inhibitor, 6-chloro-3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-1H-indole-2-carboxylic acid, we applied a fragment-based approach to obtain new molecules that extended into the p1 pocket of the BH3 groove and then exhibited binding selectivity for the Mcl-1 over the Bcl-2 protein. After we deconstructed the 1H-indole-2-carboxylic acid from the parental molecule, a benzenesulfonyl was substituted at the 1-position to adopt a geometry preferred for accessing the p1 pocket according to the binding mode of the parental molecule identified by X-ray crystallography. A linear relationship between the free energy of ligand binding (Delta G) and the count of non-hydrogen heavy atoms (HAC) was maintained during the molecular growing to occupy the p1 pocket. Finally, we not only obtained compound 12 with a 7.5-fold selectivity to Mcl-1 (K-i = 0.48 mu M by fluorescence polarization) over Bcl-2 (K-i = 3.6 mu M), but also provided evidence that additional occupation of the p1 pocket is more favorable for Mcl-1 than for Bcl-2 binding, and contributes more to Mcl-1 inhibition than occupation of the p2 pocket. Compound 12 exhibited a selective killing ability on Mcl-1-dependent cancer cells.
引用
收藏
页数:12
相关论文
共 50 条
[21]   Design, synthesis and preliminary bioactivity studies of indomethacin derivatives as Bcl-2/Mcl-1 dual inhibitors [J].
Chen, Chen ;
Nie, Yiming ;
Xu, Guangsen ;
Yang, Xinying ;
Fang, Hao ;
Hou, Xuben .
BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (13) :2771-2783
[22]   3-Substituted-N-(4-Hydroxynaphthalen-1-yl)arylsulfonamides as a Novel Class of Selective Mcl-1 Inhibitors: Structure-Based Design, Synthesis, SAR, and Biological Evaluation [J].
Abulwerdi, Fardokht A. ;
Liao, Chenzhong ;
Mady, Ahmed S. ;
Gavin, Jordan ;
Shen, Chenxi ;
Cierpicki, Tomasz ;
Stuckey, Jeanne A. ;
Showalter, H. D. Hollis ;
Nikoovska-Coleska, Zaneta .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (10) :4111-4133
[23]   1-Sulfonylated 1,2,3,4-tetrahydroquinoline-6-carboxylic acids as simple, readily-accessible MCL-1 inhibitors [J].
Chen, Lijia ;
Chan, Alexandria M. ;
Wilder, Paul T. ;
Fletcher, Steven .
DRUG DEVELOPMENT RESEARCH, 2022, 83 (08) :1879-1889
[24]   Discovery and development of substituted tyrosine derivatives as Bcl-2/Mcl-1 inhibitors [J].
Liu, Renshuai ;
Liu, Lulu ;
Liu, Tingting ;
Yang, Xinying ;
Wan, Yichao ;
Fang, Hao .
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (17) :4907-4915
[25]   Design, synthesis and anticancer activity studies of novel indole derivatives as Bcl-2/Mcl-1 dual inhibitors [J].
Liu, Yingfei ;
Li, Jianjun ;
Zhou, Guanghui ;
Zhang, Jiale ;
Teng, Yu ;
Bai, Zhushuang ;
Liu, Tingting .
MEDICINAL CHEMISTRY RESEARCH, 2023, 32 (01) :99-108
[26]   Structure-based design of N-substituted 1-hydroxy-4-sulfamoyl-2naphthoates as selective inhibitors of the Mcl-1 oncoprotein [J].
Lanning, Maryanna E. ;
Yu, Wenbo ;
Yap, Jeremy L. ;
Chauhan, Jay ;
Chen, Lijia ;
Whiting, Ellis ;
Pidugu, Lakshmi S. ;
Atkinson, Tyler ;
Bailey, Hala ;
Li, Willy ;
Roth, Braden M. ;
Hynicka, Lauren ;
Chesko, Kirsty ;
Toth, Eric A. ;
Shapiro, Paul ;
MacKerell, Alexander D., Jr. ;
Wilder, Paul T. ;
Fletcher, Steven .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 113 :273-292
[27]   Discovery of Tricyclic Indoles That Potently Inhibit Mcl-1 Using Fragment-Based Methods and Structure-Based Design [J].
Burke, Jason P. ;
Bian, Zhiguo ;
Shaw, Subrata ;
Zhao, Bin ;
Goodwin, Craig M. ;
Belmar, Johannes ;
Browning, Carrie F. ;
Vigil, Dominico ;
Friberg, Anders ;
Camper, DeMarco V. ;
Rossanese, Olivia W. ;
Lee, Taekyu ;
Olejniczak, Edward T. ;
Fesik, Stephen W. .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (09) :3794-3805
[28]   Development of a series of novel Mcl-1 inhibitors bearing an indole carboxylic acid moiety [J].
Deng, Hongguang ;
Huang, Min ;
Liu, Hui ;
Zhang, Hong ;
Liu, Liang ;
Gao, Bensheng ;
Li, Xianlu ;
Li, Jinbo ;
Niu, Qun ;
Zhang, Zhenwei ;
Luan, Shenglin ;
Zhang, Jingyi ;
Jing, Yongkui ;
Liu, Dan ;
Zhao, Linxiang .
BIOORGANIC CHEMISTRY, 2022, 127
[29]   Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as novel HIV-1 integrase strand transfer inhibitors [J].
Zhang, Rong-Hong ;
Chen, Guo-Qi ;
Wang, Weilin ;
Wang, Yu-Chan ;
Zhang, Wen-Li ;
Chen, Ting ;
Xiong, Qian-Qian ;
Zhao, Yong-Long ;
Liao, Shang-Gao ;
Li, Yong-Jun ;
Yan, Guo-Yi ;
Zhou, Meng .
RSC ADVANCES, 2024, 14 (13) :9020-9031
[30]   Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors [J].
Murray, Christopher W. ;
Berdini, Valerio ;
Buck, Ildiko M. ;
Carr, Maria E. ;
Cleasby, Anne ;
Coyle, Joseph E. ;
Curry, Jayne E. ;
Day, James E. H. ;
Day, Phillip J. ;
Hearn, Keisha ;
Iqbal, Aman ;
Lee, Lydia Y. W. ;
Martins, Vanessa ;
Mortenson, Paul N. ;
Munck, Joanne M. ;
Page, Lee W. ;
Patel, Sahil ;
Roomans, Susan ;
Smith, Kirsten ;
Tamanini, Emiliano ;
Saxty, Gordon .
ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (07) :798-803